Cicaplast Baume B+5 Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

La Roche-Posay is the best-performing cicaplast baume b+5 brand in July 2026, moving 260,000 units across 6 ASINs for 81.3% of Top 10 volume. Cetaphil follows with 20,000 units (6.3%), ahead of AESTURA on 20,000 units (6.3%).

With 5 brands splitting the Top 10 and 93.8% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $10.99 to $32.00, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. On the growth side, B08Q7LYHSZ leads positive momentum with ▲ 100.0% MoM growth on 4K units, with B0FHY2QMRK close behind at ▲ 100.0% MoM on 2K units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.